🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laura Linville

Inova Health System

ORCID: 0000-0001-6993-3421

Also affiliated with Virginia Cancer Institute, Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations”.

TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations

(2024)10.1093/oncolo/oyae120

N/A

0.687DataRank · unranked

14 citations

Cora N. Sternberg, Hao Wang, Tingchang Wang, Laura Linville, Catherine H. Marshall +5 more

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

npj Breast Cancer(2020)10.1038/s41523-020-00184-7

N/A

0.470DataRank · unranked

22 citations

Hannah Oh, Andriy Derkach, Joshua N. Sampson, Brian L. Sprague, Pamela M. Vacek +19 more

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion

JCO Precision Oncology(2024)10.1200/po.24.00254

N/A

0.284DataRank · unranked

5 citations

Jaime Wehr, Katerina Karaindrou, Rena R. Xian, Christopher D. Gocke, Ming‐Tseh Lin +35 more